United States · Platforms & data · Yahoo Finance

Zymeworks stock surges on $813M Roche licensing deal

Published by Yahoo Finance · United States 8 h ago

Zymeworks Inc (NASDAQ:ZYME) shares rose 5.5% in premarket trading Friday following the announcement of a global license and collaboration agreement with Roche for ZW209, a T cell…

Read the full article on Yahoo Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

The Motley Fool

Not Nvidia. Not Micron. This Little-Known Chip Stock Is the AI Boom's Best-Kept Secret.

MarketBeat

Pinnacle Financial Partners (NYSE:PNFP) Price Target Raised to $118.00

Seeking Alpha

Celestica Q3 2026 earnings preview: Analysts expect wide Y/Y growth

MarketWatch

We have a $300,000 mortgage with a 2.75% interest rate. I want to pay it off. My husband says I’m crazy. Who’s right?

Investing.com

Earnings call transcript: Ameris Bancorp tops Q3 2026 EPS forecast

Benzinga